O

Omada Health

Virtual care provider delivering chronic-condition management

Vice President Employer Sales

Full-Time
No salary listed
Expert
Remote in USA
Remote
Sales & Account ManagementAccount Executive

About the job

Requirements
  • At least 15 years of progressive experience in enterprise sales or commercial leadership, including significant experience leading leaders and scaling high-performing sales organizations.
  • Deep experience selling complex healthcare, health technology, benefits, or adjacent solutions to large employers and sophisticated healthcare buyers.
  • Strong knowledge of the employer healthcare ecosystem, including consultants, brokers, health plans, pharmacy benefit managers, and strategic distribution partners.
  • Proven success closing large, complex, multi-stakeholder enterprise deals and building trusted relationships with C-suite buyers.
  • Proven ability to lead organizational change, develop strong sales leaders, and make sound decisions across talent, performance, and organizational design.
  • Experience in digital health, virtual care, population health, benefits technology, health plans, healthcare services, or adjacent healthcare technology.
  • Experience in chronic condition management, cardiometabolic health, GLP-1 care, or other high-value healthcare categories.
Responsibilities
  • Own new business and expansion Covered/Contract Lives and bookings across employer segments, translating company growth priorities into clear strategy, targets, and execution.
  • Partner with Product, Clinical, Marketing, Customer Success, Payer, Consulting Relations, Legal, and Finance to align on strategy, unlock upsell, and translate customer insight into product and clinical priorities.
  • Build a predictable, scalable growth engine with discipline across pipeline, conversion, forecasting, sales cycles, and representative productivity.
  • Balance near-term performance with long-term growth, making tradeoffs across segments, channels, talent, and investment.
  • Serve as a senior voice of the employer market, bringing buyer, competitive, benefits, and healthcare economics insights into commercial strategy.
  • Partner with Marketing, Revenue Operations, Product, and Payer on ideal customer profile, territory design, segmentation, and channel strategy across employers, health plans, pharmacy benefit managers, and the consultant/broker channel.
  • Evolve segmentation, account coverage, sales motions, channel strategy, value proposition, pricing, and packaging to improve market fit and growth.
  • Partner across Marketing, Product, Clinical, Design, and Commercial Operations to align offerings and investments to high-value opportunities.
  • Build trusted executive relationships with priority employers and C-suite buyers, and personally support complex, high-value deals and negotiations.
  • Coach Sales Directors and Account Executives on deal strategy, executive engagement, competitive positioning, and close planning.
  • Partner with Payer, Alliances, and Consulting Relations to expand reach through health plans, pharmacy benefit managers, consultants, brokers, and other strategic channels.
  • Lead, develop, and retain Sales Directors and Account Executives across employer segments.
  • Build a strong leadership bench, clear accountability, and the organizational structure and coverage model required to scale.
  • Create a culture of high performance, learning, collaboration, and customer focus, evolving the organization as the market and business change.
  • Bring the voice of the employer market into product, clinical, customer experience, and commercial decisions.
  • Partner across Product, Clinical, Marketing, Customer Success, Finance, Payer, and Commercial Operations to remove barriers to growth and strengthen the full customer lifecycle.
  • Translate customer and market insights into actionable recommendations for the leadership team.
Desired Qualifications
  • Deep operating knowledge of the MEDDPICC sales methodology or a comparable enterprise sales qualification and deal-management framework, with the ability to embed it into pipeline management, forecasting, coaching, and team execution.
  • An established network of executive-level relationships across the benefits, consulting, and pharmacy benefit management sectors.
  • Demonstrated success improving talent outcomes, productivity metrics, and pipeline performance within organizations generating approximately $300 million to $1 billion in annual revenue.
  • A proven, balanced approach to developing talent using leadership judgment and data-driven performance practices to build high-performing teams and environments.

About the company

Omada Health provides virtual-first, integrated care with clinically supported programs for chronic conditions. Its online programs use evidence-based medical protocols combined with behavior science, delivered with the help of health coaches and clinical specialists to help people achieve long-term health improvements. The company serves over 1,600 enterprise customers and partners with major employers, health plans, and health systems, delivering personalized interventions for diabetes prevention, weight management, diabetes, hypertension, musculoskeletal issues, and behavioral health. Its goal is to make sustained healthy behavior possible by offering accessible, scalable care that reduces healthcare costs and improves ROI for partners.

Company Size

501-1,000

Company Stage

IPO

Headquarters

South San Francisco, California

Founded

2011

Get referred to Omada Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 6, 2026 revenue reached $88 million, up 43%, with $5 million net income.
  • Omada raised 2026 guidance to $334 million-$340 million and $21 million-$27 million EBITDA.
  • HCSC's expanded coverage added 1.5 million lives, and first cholesterol deployment started July 2026.

What critics are saying

  • Omada depends on a few channel giants; HCSC, Optum Rx, and Lilly control access.
  • Sean Duffy's 2027 CEO handoff risks execution drift during commercialization and profitability scaling.
  • Noom, Teladoc, and Hinge Health attack Omada's employer and payer contracts by program specialization.

What makes Omada Health unique

  • Omada's August 2026 platform spans diabetes, hypertension, cholesterol, obesity, and MSK care.
  • Omada integrates human coaches, connected devices, and AI, unlike single-condition point solutions.
  • Omada's August 2026 PBM reach includes Optum Rx, Eli Lilly, and HCSC.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote first - Join Omada from anywhere in the US. No matter where you’re located, we budget for travel so your team can come together.
  • Flexible vacation - Invest in yourself and your loved ones with flexible time away and monthly wellness days.
  • Parental leave - We support all new parents with competitive leave policies and flexible schedules upon return.
  • Omada program - Join our best-in-class program to reach your health goals, and invite a loved one to join you too.
  • Meeting-free days - Every Wednesday afternoon, we observe company-wide focus time with nothing on the calendar.
  • Resources to thrive - Invest in inclusion with resource groups, equity training, and a cross-functional team dedicated to belonging.

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

1%

2 year growth

1%
Yahoo Finance
Sep 23rd, 2026
Omada Health president sells $236K in shares under pre-set trading plan

Wei-Li Shao, president of Omada Health, sold 9,418 shares for approximately $236,000 on 12 August 2026, according to an SEC filing. The transaction was executed under a Rule 10b5-1 trading plan established in March 2026. Shao retains over 307,000 shares valued at roughly $7 million following the sale. At the time of the transaction, Omada Health shares had appreciated 24% over the preceding 12 months. Omada Health provides virtual care programmes for cardiometabolic conditions including prediabetes and hypertension. The company reported trailing-twelve-month revenue of $309.8 million and net income of $4.3 million, with a market capitalisation of $1.3 billion and 946 employees.

Associated Press
Sep 10th, 2026
Omada Health targets 80% gross margin and 30% EBITDA as revenue nearly triples to $310M

Omada Health held its inaugural Investor Day in New York, unveiling updated long-term financial targets. The virtual-first healthcare provider announced expectations of at least 20% annual revenue growth, 80% non-GAAP gross margin, and 30% adjusted EBITDA margin. From fiscal 2023 through the second quarter of 2026, Omada nearly tripled its member base from approximately 0.3 million to 1.09 million and grew revenue from approximately $123 million to $310 million. During this period, gross margin expanded from 57% to 68%, whilst non-GAAP gross margin increased from 60% to 70%. The company expects continued growth through partnerships with Optum Rx and Health Care Service Corporation. Omada plans to leverage AI-enabled automation, improved coach productivity, and increased care delivery efficiency to achieve its targets. The company has served over two million members across 2,000 employers, health plans, and health systems.

Yahoo Finance
Sep 9th, 2026
Omada Health CEO Sean Duffy sells 31,457 shares worth $735,150 under trading plan

Omada Health CEO Sean Duffy sold 31,457 shares on 1 September 2026, according to an SEC filing. The transaction was valued at approximately $735,150, with shares sold at a weighted average price of $23.37. Of the total, 21,572 shares were sold on the open market, whilst 9,885 shares were used to satisfy tax withholding obligations related to vesting equity awards. The entire transaction was executed under a Rule 10b5-1 trading plan established on 13 March 2026. Following the sale, Duffy holds approximately 1.3 million shares of common stock directly and through family trusts, plus 512,994 outstanding options. The company, which provides virtual care programmes for chronic disease management, reported $309.80 million in revenue and $4.30 million in net income on a trailing twelve-month basis.

Yahoo Finance
Aug 7th, 2026
Omada Health hits $88M revenue, swings to $5M profit with 45% member growth

Omada Health reported record second-quarter revenue of $88 million, up 43% year-over-year and 13% sequentially. The digital health company achieved GAAP net income of more than $5 million, compared with a net loss of approximately $5 million in the same quarter last year. Gross margin reached 73% on a GAAP basis, up from 66% in the prior-year quarter. Adjusted EBITDA was approximately $11 million, marking a quarterly record and an $11 million improvement year-over-year. Total members grew 45% year-over-year to approximately 1.1 million, driven by broad enrollment growth across its cardiometabolic programmes. The company raised its full-year revenue guidance to $334 million to $340 million, up from previous guidance of $322 million to $330 million. Adjusted EBITDA guidance was increased to $21 million to $27 million.

Fierce Healthcare
Aug 6th, 2026
Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy.

Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy. Omada Health announced a leadership shift as Wei-Li Shao, who currently serves as president, will become CEO, effective January 1. Sean Duffy, founder and CEO, will transition to founder and executive chair, supporting Shao and the Board on Omada Health's long-term mission, key partnerships and strategic initiatives, the company announced Thursday in conjunction with its second-quarter earnings results. Shao joined Omada Health in 2019 as chief commercial officer and was appointed president in 2021. As president, he has held "direct accountability for Omada Health's P&L and full operating agenda, leading the product, commercial and operational strategy that scaled the company from a single-condition program into a multi-condition care platform," the company said in a press release. "He built the long-range plan that guides how Omada Health runs today and has been a close strategic partner to Sean throughout the company's growth," management said. Prior to Omada Health, Shao spent 18 years at Eli Lilly and Company, where he held senior leadership roles across its global healthcare and biopharmaceutical businesses, including experience in the cardiometabolic and diabetes markets, which align with Omada Health's business focus. "Over the past seven years, Wei-Li and I have worked together to build a strong company as Wei-Li has steadily increased his scope of responsibility. His track record of delivering innovation, commercial wins, and strong financial growth has shaped Omada and demonstrates that Wei-Li is the right leader to take Omada to the next level of impact and scale," Duffy said in a statement. "Fifteen years ago, Sean designed an innovative solution to help Americans bridge the healthcare gap. Together, we've shown the model works, yet I believe our biggest impact is still ahead. Our results serve as a foundation to raise our ambitions. Now is the time to scale, push harder on our mission, and bend the curve of chronic disease," Shao said in a statement. The virtual care provider reported strong growth driven by demand for its integrated approach to managing chronic conditions such as diabetes, hypertension, obesity and musculoskeletal disorders. The company continues to expand its portfolio of multiple chronic condition programs for its existing customer base of employers and health plans, while also broadening its commercial reach through its GLP-1 capabilities and new cholesterol care track. Omada Health, which went public in June, ties remote monitoring devices with coaching and artificial intelligence to help consumers control their chronic diseases. The company supports diabetes, hypertension, cholesterol, obesity and musculoskeletal conditions and leans on its multi-condition approach to differentiate itself from competitors. The company works with more than 2,000 employers and health plans today. "We just reported our strongest quarter ever, reaching a record number of members and our highest revenue and gross margin to date, with more than 2 million lifetime members served, commercial relationships with the nation's three leading PBMs (pharmacy benefit managers) and a proven and profitable model," Duffy told investors and analysts on the Q2 earnings call. Omada Health's membership grew 45% year-over-year, "reflecting continued demand across Omada Health's integrated cardiometabolic care platform and strong enrollment momentum across diabetes and hypertension programs," management said in a press release on its Q2 results. The company brought in revenue of $88 million in Q2, up 43% from $61 million the same period a year ago, and reported profit of $5 million, compared with a net loss of $5 million in Q2 2025. Omada Health's adjusted EBITDA in the quarter was $11 million, compared with an adjusted EBITDA loss of $200,000 a year ago. The company reported gross margin of 73% in the second quarter, up from 66% in Q2 2025. "This marks Omada Health's most profitable quarter to date, both in absolute terms and on a margin basis, demonstrating continued operating leverage," said Steve Cook, Omada Health's chief financial officer, in a statement. "At the midpoint, our raised full-year outlook represents approximately 30% year-over-year revenue growth and a fourfold increase in adjusted EBITDA, reflecting our extraordinary second-quarter performance and our path of sustainable profitability." The company highlighted recent milestones including an expanded partnership with Health Care Services Corporation that extends its prevention and weight health and hypertension management programs across HCSC's fully insured book of business in Illinois, Oklahoma, and New Mexico, reaching an additional 1.5 million covered lives. In February, the company announced its Omada for Cholesterol program to bring its artificial-intelligence-powered and human-led coaching approach to cholesterol management and embed it within the broader platform for managing weight, blood pressure and diabetes. The company announced the first deployment of its cholesterol management offering in July, expanding personalized multi-condition care for employees of one of the nation's largest retailers, management said. In May, the company announced it had signed on with Optum Rx to participate in its Weight Engage program, marking the company's first offering of prescribing capabilities within a pharmacy benefit manager channel. During Q2, the company closed its first customer for the prescribing program and management expects that program to yield revenue in 2027, signaling early market demand and future revenue potential. "Our outstanding second quarter reflects the strength of our strategy, the momentum we've built across the business, and the exceptional team driving Omada forward," Duffy said. "Reflecting continued demand for our integrated between-visit care platform, total members increased 45% year over year as we expanded our commercial channels, deepened relationships with our leading PBM channels, and introduced our cholesterol management program with one of the nation's largest retailers. The opportunity ahead is significant, and we'll remain focused on disciplined execution as we look to broaden our capabilities, deepen customer relationships and improve the health of even more members." Omada Health hiked its 2026 outlook and is now forecasting revenue in the range of $334 million to $340 million, with the midpoint representing 30% growth compared with 2025. This range is up from the prior range of $322 million to $330 million. The company projects adjusted EBITDA in the range of $21 million to $27 million, with the midpoint representing a four times increase compared with 2025, and this range is up from the prior range of $14 million to $20 million. Editor's Note: This is a developing story and will be updated following the Q2 earnings call. Let Google know we are your trusted source. Add our editorial as a preferred source in your search results.